Tides Medical Upgrades Lafayette, Louisiana, Headquarters-Manufacturing Center
03/01/2023
The expansion will allow the company to increase production of its amniotic skin substitutes, according to company officials. Upgrades are planned for completion by the end of the year.
“We believe that Louisiana biotech companies like Tides Medical play an important role in saving limbs and lives through the development and manufacturing of advanced treatments like our Artacent products for chronic wounds,” Tides Medical CEO Joe Spell said. “As our population ages, we must invest in solutions that will prevent negative outcomes for patients with chronic wounds, including millions that receive no advanced wound care treatment today. We can do that here in Louisiana by creating quality jobs, and funding innovative research and development.”
The state of Louisiana offered Tides Medical a an incentives package that includes a $200,000 performance-based grant for reimbursement of equipment expenditures, contingent upon the meeting of employment and payroll targets. The company is also expected to participate in the state’s Industrial Tax Exemption and Quality Jobs programs.
“Louisiana is proud to have Tides Medical as a part of the state’s vibrant and expanding life science sector,” noted Governor John Bel Edwards. “My administration is committed to growing and diversifying our economy through industries like biotechnology, and this is another milestone in our work. This expansion will allow Tides Medical to expand its mission to provide safe, effective treatments that improve health outcomes around the country while also creating good-paying jobs in Acadiana.”
Tides Medical is a biotechnology company that sources and acquires donated placentas to manufacture, distribute and provide amniotic tissue products that will lessen the societal impact of chronic wounds. The company also works closely with physicians and their staff to help them navigate the complex reimbursement process, ensuring that patients have access to the full range of treatment options they deserve.
“We are thrilled to share the news of Tides Medical’s manufacturing facility and headquarters expansion,” added Lafayette Economic Development Authority President and CEO Mandi D. Mitchell. “Since establishing in Lafayette in 2009, Tides has been an innovator in the biotechnology field serving clients across the U.S. I applaud CEO Joe Spell for choosing to grow this company right here at home, and I look forward to seeing Tides Medical continue its growth in Lafayette with 40 new direct jobs in the high-wage, high-demand medical and manufacturing fields.”
Project Announcements
Japan-Based TOCALO Plans Chandler, Arizona, Operations
04/17/2026
Dakota Bodies Expands Liberty, Missouri, Operations
04/17/2026
Linde Plans Garysburg, North Carolina, Air Separation Operations
04/17/2026
Netherlands-Based Signature Foods USA Plans Easley, South Carolina, Manufacturing Operations
04/16/2026
Lumber Liquidators Plans Lawrenceburg, Tennessee, Headquarters Operations
04/16/2026
Canada-Based Bioriginal Food & Science Plans Grand Junction, Colorado, Operations
04/15/2026
Most Read
-
Economic Developer Role Shifting from Deal-Making to Systems Stewardship
Q1 2026
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
Last Word: Don’t Lose by Winning
Q1 2026
-
Where Workforce Capacity Is Being Built — and Where It’s Being Deployed
Q1 2026
-
Advanced Manufacturing Isn’t a Buzzword—It’s a Different Location Strategy
Q1 2026